Clinical trial
Neurofeedback in Individuals With Substance Use Disorders
NCT04188288 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurofeedback in Individuals With Substance Use Disorders
- Lead sponsor
- Yale University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 1, 2021
- Completion date
- March 15, 2023
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.